Resection of primary tumors is often followed by accelerated growth of metastases. Here we propose that this effect may be due to the fact that resection of primary tumor results in a decrease in the total systemic amount of angiogenesis stimulators, such as VEGF and bFGF. This in turn causes decrease in the systemic level of angiogenesis inhibitors, such as PF-4 and TSP-1, which at least temporarily relieves inhibition of secondary tumors, allowing them to grow. This construct is predicated on the notion that systemic level of angiogenesis inhibitors is regulated by the systemic level of angiogenesis stimulators, as the host is trying to maintain the homeostatic balance of stimulators to inhibitors in the body. We evaluate this hypothesis using a conceptual mathematical model and show that indeed, this mechanism can explain accelerated growth of secondary tumors following resection of a primary tumor. We also show that there exists a tradeoff between time of surgery and time to onset of metastatic growth. We conclude with a discussion of possible therapeutic approaches that may counteract this effect and reduce metastatic recurrences after surgery.
Introduction
Metastases are a primary cause of death of cancer. It is likely that secondary tumors have been seeded early in tumor development (1) . Furthermore, there exist numerous observations that surgical removal of primary tumors can lead to increased growth of secondary tumors (2) (3) (4) (5) (6) , suggesting that primary tumors may have had some inhibitory effect on metastases. This phenomenon has been observed in colorectal cancer (5) , non-small-cell lung cancer (7) , among other cancer types.
A number of hypotheses have been proposed to explain this observation, including monopolization of resources by the primary tumor, depriving secondary tumors of necessary nutrients; immune stimulation, induced by the primary tumor, which causes cross-immunity and thus suppression of secondary tumors (8) (9) (10) ; intrinsic population heterogeneity which dictates time to escape from dormancy regardless of extrinsic events (11) , among others. Here we explore another possibility, which focuses on the systemic response of the host to tumorinduced production of angiogenesis stimulators, and on the long-term effects of the altered balance between angiogenesis stimulators and inhibitors in the presence of more than one tumor in the host's body.
Tumors cannot grow beyond 1-2mm 3 without recruiting their own blood supply, a process that has been known as 'angiogenic switch' (12) (13) (14) . The ability of a tumors to recruit their own blood supply relies in part on a tumor-induced shift in the balance between proangiogenic and anti-angiogenic proteins away from the normal physiological 'off' state (15) . This is achieved when the pro-angiogenic effects of continuously produced angiogenesis stimulators, such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), overwhelm the inhibitory effects of angiogenesis inhibitors, such as platelet factor 4 (PF-4), thrombospondin-1 (TSP-1), angiostatin and endostatin (15) (16) (17) (18) .
Angiogenesis stimulators, such as VEGF, induce formation of early vascular sprouts, or tip cells (19) . Sprout growth and lumenization (formation or stalk cells) is facilitated by factors, such as bFGF (20) , henceforth for brevity referred to as blood vessel stabilizers. All of these angiogenesis regulators bind to the same binding cite, namely, heparan sulfate (21) (22) (23) (24) .
Angiogenesis inhibitors facilitate termination of neovascularization either by outcompeting angiogenesis stimulators due to high affinity for heparin, as is the case for PF-4 (25) or via repressing anti-apoptosis genes and inhibiting factors involved in cell cycle arrest, causing proliferating cells to become apoptotic, as is the case for endostatin and angiostatin (26, 27) .
In (28) Here, we build on this work to investigate a hypothesis about mechanisms that can underlie escape from metastatic tumor dormancy, and specifically, the observation that secondary (metastatic) tumors may experience accelerated growth following resection of a primary tumor.
Many tumors are characterized by increased production of angiogenesis stimulators, such as VEGF (29) (30) (31) . Furthermore, it has been observed that the level of inhibitors in the tumor host is also elevated, production of which has been attributed to the tumors themselves, suggesting a degree of self-inhibition (32) (33) (34) . This hypothesis was mathematically investigated by Benzekry et al. (35) , where the authors identified ranges of parameter values that allow for an organism-level homeostatic steady state in total tumor burden through mutual angioinhibitory interactions within a population of tumor lesions that could yield global dormancy.
Here we propose an alternative model to explain a possible mechanism, whereby secondary tumors might undergo accelerated growth following removal of the primary tumor.
Specifically, a possible explanation for the presence of high levels of inhibitors is the normal 4 tissues' response to increased presence of angiogenesis stimulators. This increase would occur in order to restore the homeostatic ratio of angiogenesis stimulators to inhibitors within the host, returning it to the physiologically normal 'off' state. Gonzalez et al. have shown that the ratio of inhibitors to stimulators, such as TSP-1 to VEGF, in serum and in serum minus plasma, is twice to three times as high in healthy subjects as it is in cancer patients (36) . Furthermore, some preliminary data suggest that injection of VEGF into mice resulted in increased levels of angiogenesis inhibitors (Giannoula Klement, personal communication), suggesting that increase in level of stimulators would be followed by increase in systemic levels of angiogenesis inhibitors, as the body would attempt to suppress unnecessary neovascularization.
If the body indeed responds with increasing production of angiogenesis inhibitors in an attempt to compensate for increased stimulator production to restore the state of homeostasis, This scenario requires the following assumptions to hold:
1) Levels of angiogenesis inhibitors are responsive to the current levels of angiogenesis stimulators, i.e., when the concentration of angiogenesis stimulators increases, the host's body tries to restore homeostatic ratio of angiogenesis regulators by increasing the levels of inhibitors.
2) There exists a threshold of sensitivity of inhibitors to the presence of angiogenesis stimulators in the body of the host, such that when the total amount of stimulators is above this threshold, secretion of inhibitors increases in order to compensate for stimulator increase; below this threshold, the amount of inhibitors returns to homeostatic levels (15) .
This scenario is summarized in Figure 1 . reported that plasma endostatin levels were significantly higher in the 30 patients compared to controls before surgery. However, none of the patients who remained progression free had elevated endostatin levels at follow up. Several studies also report that elevated post-operative endostatin levels were associated with poor prognosis for patients with advanced stage nasopharygeal carcinoma (40) and for human malignant gliomas (41), potentially suggesting presence of metastatic tumors.
Here, we introduce a proof of concept model, which captures the scenario described above. We identify the necessary assumptions and perform sensitivity analysis in order to identify key parameters that may be driving system dynamics. We demonstrate that indeed, surgical removal of the primary tumor can lead to a cascade of responses that would result in releasing the inhibitory effect on the secondary tumor(s), providing a possible explanation for accelerated growth of metastases following resection of the primary tumor. We conclude with a discussion of therapeutic options.
Model description
In order to evaluate the hypothesis that the host's response to removal of primary tumor 
We expect that given our understanding of the system, we will see the dynamics as depicted on Figure 2 , where without surgery the overall levels of angiogenesis stimulators will remain high, causing high levels of angiogenesis inhibitors and consequent suppression of the secondary tumor. However, in the event of a surgery, amount of inhibitors will decrease, causing increase in the growth of secondary tumors.
Figure 2.
Schematic representation of the anticipated dynamics of tumor, neovasculature, stimulators and inhibitors with and without surgery. We expect that without surgery, the level of angiogenesis inhibitors will remain high, inhibiting secondary tumor growth. However, we predict that after resecting the primary tumor, the level of inhibitors will decrease due to decrease of overall stimulator levels, causing accelerated growth of the secondary tumor.
We propose that the change in volume of the primary tumor 1 () Tt is described by an
Allee-type growth function with a dynamic carrying capacity Here, we will describe the dynamics of tumor-induced vasculature, as well as tumorinduced production of angiogenesis stimulators, and the systemic response to them of angiogenesis inhibitors. That is, we are looking at levels of angiogenesis regulators, as well as neovasculature created above the body's normal baseline. For this reason, in the absence of a tumor, the level of tumor-induced stimulators will tend to zero. In the presence of a tumor, there exists a tumor-induced inflow of angiogenesis stimulators, described by the ratio dependent functional form
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, where production of additional stimulators is proportional to the ratio of
( ) / ( ) T t S t . This functional form allows additional tumor-induced
production of stimulators to be dependent both on the current amount of stimulators, and on the volume of tumor present. We also assume there to be some natural clearance rate of angiogenesis stimulators, described by
The equation for angiogenesis inhibitors
() It is derived in the following way.
Angiogenesis stimulators
() It will increase if the total sum of angiogenesis stimulators 12 Taking into account all of these considerations, we obtain the following system of equations: 
All of the variables and parameters for System (1), as well as sample parameter values and initial conditions, are summarized in Table 1 . 
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Sensitivity Analysis
Due to lack of consistent experimental data for the proposed proof-of-concept model, most parameter values were chosen in such a way as to capture the theoretically predicted dynamics. That is, our goal is to evaluate whether the proposed set of assumptions would be sufficient to reproduce the qualitative pattern of expected behavior. Despite this limitation, we can use sensitivity analysis to discern relative importance of various parameters in the system over time.
Within each parameter there can be significant variability. Moreover, low dimensionality of the proposed model may result in compression of several parameter values into the same parameter, introducing further variability. In order to evaluate, which parameters in System (1) would have the largest impact on the overall system dynamics at various time points, we perturbed each parameter by a uniformly distributed random variable within the range of 15% of the initial parameter value. The sensitivity indices, which are defined as fractions of total output variance generated by the uncertainty in the respective parameter value, were calculated using the Fourier Amplitude Sensitivity Test (FAST) method (46) Out of the seven parameters that were identified using the FAST method (Figure 3a ), we will vary only 1  and 1 r , which describe rate of stimulator-dependent vasculature formation, and rate of tumor-induced production of stimulators, respectively. In the next section, these two parameters will be the only ones that differ between T1 and T2. This will allow us to narrow our investigation down to effects of tumor-induced vasculature formation and not on individual intrinsic tumor properties.
Results
In order to evaluate our hypothesis that resection of a primary tumor may lead to decrease in systemic level of inhibitors, facilitating growth of secondary tumors, we performed a series of numerical experiments, where we simulated resection of the primary tumor, and evaluated how quickly secondary tumors start growing compared to scenario with no tumor resection. All the parameter values were taken from Table 1.
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As one can see in Figure 4 , without resection, the size of the primary tumor T1 predictably keeps increasing. However, with surgery performed at t=100, removing 99.99% of the primary tumor, causing T1 size to decrease below threshold m1, secondary tumor T2 starts growing sooner than it would have without surgery.
Figure 4.
Comparison of primary and secondary tumor dynamics without surgery and with surgery at t=100. As one can see, without surgery, the primary tumor keeps growing, but with surgery, secondary tumors start growing sooner.
To better understand this effect, let us evaluate the dynamics of other components of the system, namely, the dynamics of vasculature, angiogenesis stimulators and angiogenesis inhibitors, with and without surgery.
In Figure 5 , we can see that predictably, the tumor growth dynamics (Figure 5a) corresponds to the tumor's ability to generate neovasculature (Figure 5b ). When the amount of stimulators (Figure 5c ) increases beyond threshold S1+S2>S*, amount of angiogenesis inhibitors starts rising in response, until they reach their carrying capacity Imax. This is not sufficient to overcome the driving force of angiogenesis stimulators for the primary tumor T1, but may temporarily be sufficient to halt the growth of the secondary tumor T2. 
Time to surgery and time to metastases
Finally, we investigated the effects of timing of the surgery on time to appearance of secondary tumors. We simulated surgery at t=90, t=100 and t=110. As one can see in Figure 7 , secondary tumor volume is offset by the delay in time of surgery. Therefore, there exists a tradeoff: earlier surgery will reduce the size of the primary tumor T1 (Figure 7a ), but it will also reduce the delay in time to onset of secondary tumor growth (Figure 7b ). Conversely, delaying 16 surgery would allow the primary tumor to reach a larger size, potentially making it unresectable, causing more immediate harm to the patient. Noticeably, within this construct, an important distinction needs to be made: resection of primary tumors does not induce growth of secondary tumors but simply changes time to onset of metastatic growth.
Figure 7.
Variations in time to appearance of T2 depending on timing of the surgery. Earlier surgery (top panel) results in faster growing metastases (lower panel). However, later resection of the primary tumor allows it to reach larger sizes, potentially making it unresectable and causing more immediate harm to the patient.
In order to further understand how the system changes after surgery compared to before surgery, we performed additional sensitivity analysis to identify, whether and which parameters become more or less important. Results are reported in Figure 8 . Sensitivity indices are predictably identical in the time before surgery, so we report only the changes that occur after surgery. As one can see in Figure 8 , parameters 1 r and i r have greater impact on system dynamics after the surgery than in the control case, indicating the high importance of both tumor-induced production of angiogenesis stimulators, and especially whether inhibitors can respond in time to changes in systemic levels of stimulators. The rate at which the host can adapt to the change in angiogenesis stimulators becomes a crucial factor in determining, whether secondary tumors will experience accelerated growth in the time after surgery.
Discussion
In this work we propose a theoretical construct that provides a possible explanation for accelerated growth of secondary tumors following resection of a primary tumor. We build on our previous work (18), where we looked at effects of tumor-induced stromal stimulation on time to escape from dormancy. We showed that increased production of tumor-induced stimulators, such as VEGF, bFDF and PDGF, allowed for buildup of vasculature, which eventually initiated a rapid positive-feedback loop of self-supported tumor growth.
Here we expand on that construct to investigate the systemic effects of angiogenesis regulators on growth dynamics of both primary and secondary tumors. We propose that if there exists a systemic response, whereby amount of angiogenesis inhibitors increases in response to elevated levels of angiogenesis stimulators, then resection of a primary tumor will cause an overall drop in total amount of stimulators. This would cause decrease in inhibitors, which may consequently facilitate growth of secondary tumors (Figure 1 ).
In order to evaluate this hypothesis, we created a proof-of-concept mathematical model, which tracks the dynamics of a primary tumor, a secondary tumor, their respective vasculatures, tumor-induced stimulators, and angiogenesis inhibitors. The dynamics of angiogenesis inhibitors depends on the sum of stimulators produced by both tumors in such a way that if this sum drops below a certain threshold, the amount of inhibitors decreases. We then simulated surgery by reducing the size of the primary tumor by 99.99% and observed the dynamics of secondary tumors. The theoretically predicted growth curves are shown in Figure 2 , and the results of the sensitivity analysis, which allowed identifying parameters most sensitive to perturbation, are summarized in Figure 3 .
In our numerical simulations, we showed that indeed, this mechanism, if true, can explain accelerated growth of secondary tumors following resection of primary tumor. As one can see in Figure 4 , resection of the primary tumor T1 at time t=100 reduces time to onset of secondary tumor growth compared to no surgery. In Figures 5 and 6 one can see that this effect indeed comes from temporary reduction in the amount of angiogenesis inhibitors I(t), which allows for secondary tumor to build up sufficient vasculature to overcome the inhibitory effects of
I(t).
Next, we investigated the effects of different timing of the surgery on the dynamics of the two tumors. We showed that there exists a tradeoff between surgery time and time to accelerated growth of secondary tumors: earlier surgery results in faster growth of secondary tumors, while later surgery allows the primary tumor to grow to an unresectable size, potentially causing more problems in the short term than secondary tumors would cause in the long term.
The importance of systemic response of the host to changes in angiogenesis inhibitors is highlighted by sensitivity analysis performed on System (1) with and without surgery. Results reported in Figure 8 indicate that after surgery, rates of tumor-induced production of angiogenesis stimulators and rate at which the host can respond with production of angiogenesis inhibitors are most important factors in driving system dynamics after surgery.
Therapeutic implications
Even though there exists a trade-off between surgery timing and accelerated growth of metastatic tumors, in the presence of a clinically apparent tumor, the question is not whether to resect it or wait, but how to address the danger of potential metastases. In this system, accelerated growth of secondary tumors following the resection of a primary tumor occurs when the total number of angiogenesis stimulators decreases so much as to cause decrease in the number of angiogenesis inhibitors. One possible way to address this issue would be to attempt to maintain the stimulator-inhibitor balance following surgery, either through mimicking the presence of stimulators to maintain elevated levels of inhibitors, or through extrinsically increasing number of inhibitors.
Another, perhaps complementary, approach would be to directly target the source of stimulators after surgery. Targeting the stroma with maintenance therapy, such as for ALL, where a period of high-intensity induction is followed by 2-3 years of lower-dose, higher-
